Knockin Cell Line Construction Services

Inquiry

As a preclinical CRO specializing in oncology, Alfa Cytology offers gene knockin cell line construction services utilizing CRISPR/Cas9-mediated homologous recombination to precisely integrate point mutations, reporter genes, or functional cassettes into target genomic loci, generating clinically relevant cellular models for your cancer research and drug discovery programs.

Introduction to Knockin Cell Line Construction

Gene knockin cell lines are engineered cellular models in which exogenous DNA fragments, such as point mutations, fluorescent tags, reporter genes, or therapeutic cassettes, are precisely inserted into specific genomic loci through homology-directed repair (HDR) following CRISPR/Cas9-induced double-strand breaks (DSBs). Unlike gene knockout, which disrupts gene function, knockin enables the introduction of specific genetic alterations while preserving the target gene's endogenous regulatory environment. Gene knockin cell lines are essential tools for multiple oncology research applications:

Clinical Resistance Modeling: Introducing clinically relevant point mutations (e.g., EGFR T790M, KRAS G12D) to study drug resistance mechanisms and evaluate next-generation therapeutics
Protein Tagging and Tracking: Inserting fluorescent tags (GFP, RFP, Luc) or affinity tags (Flag, HA, Myc) at endogenous loci for live-cell imaging, protein localization studies, and immunoprecipitation
Reporter System Development: Knocking in reporter genes (Luciferase, LacZ, SEAP) under endogenous promoters for real-time monitoring of gene expression or pathway activity
Generation of Isogenic Cell Lines: Creating genetically matched cell lines differing only at the target locus for precise functional comparisons and target validation
Cell Therapy Development: Safe-harbor integration of therapeutic cassettes (e.g., CAR constructs) for engineered cell therapy applications

Fig. 1 CRISPR knockin workflow in erythroleukemia cells. Fig. 1 CRISPR-Cas9-mediated fluorescent tag knockin workflow in mouse erythroleukemia cells. (Deleuze V, et al.; 2024)

Our Services

With an in-depth understanding of CRISPR gene editing and HDR optimization strategies, Alfa Cytology provides professional gene knockin cell line construction services dedicated to translating your precise genome modification needs into stable, well-characterized cellular models.

Leveraging our extensive experience in HDR optimization across diverse tumor cell lines, including strategies such as small molecule HDR enhancers (e.g., RS-1, SCR7), RNP delivery, and optimized donor vector design, we ensure that every gene knockin cell line exhibits precise integration, proper expression, and stable genetic characteristics, providing reliable cellular tools for your resistance mechanism studies, protein function analysis, and drug discovery programs.

Service Details

Service Step	Service Details	Turnaround Time
Knockin Strategy Design	Design sgRNAs targeting the desired integration site, construct donor vectors with homology arms (0.8–1.5 kb each) flanking the knockin cassette, and complete sequence verification. Selection of appropriate HDR enhancer strategies based on cell type and insert size.	2–3 weeks
Donor Vector Construction	Homology arm cloning and sequence verification Optional selection markers (antibiotic resistance/fluorescence) Insert fragment synthesis (point mutations/tags/reporter genes) Sequence verification	2–3 weeks
Cell Transfection and HDR Induction	Co-deliver CRISPR/Cas9 components (plasmid/RNP) and donor vectors via lipid-based, electroporation, or lentiviral methods. Optimize HDR efficiency using enhancer molecules or cell cycle synchronization when necessary.	2–3 weeks
Single-Cell Isolation	Isolate single cells into 96-well plates via limiting dilution or FACS sorting to ensure monoclonality and enable screening of correctly targeted clones.	1 week
Clone Screening and Genotype Confirmation	Expand clones from 96-well to 6-well plates, screen by junction PCR and Sanger sequencing to identify correctly targeted clones. Distinguish between heterozygous and homozygous knockin events. Down-select to 2–3 validated clones.	6–8 weeks
Expression Validation	Confirm knockin expression at mRNA (qPCR) and protein (Western blot, flow cytometry, fluorescence microscopy) levels. Assess tag function or reporter activity as applicable.	2–3 weeks
Off-Target Analysis	Bioinformatics prediction of top 5–10 off-target sites. Target site amplification and sequencing validation. Gene editing specificity confirmation.	2–3 weeks
Cell Banking and Quality Release	Establish master cell bank (MCB) and working cell bank (WCB). Complete full release testing and issue a comprehensive COA.	3–4 weeks

Deliverables

Cryopreserved knockin cell line (≥2 clones recommendedl)
Control cell line (parental cells)
Cell viability report
sgRNA target sequences and knockin strategy documentation
Donor vector sequence and construction report
Genotype confirmation data (junction PCR and Sanger sequencing chromatograms)
Heterozygous/homozygous status identification
Expression validation data (qPCR, Western blot, or fluorescence/flow cytometry)
Off-target effect analysis report (optional)
STR cell line authentication report
Mycoplasma testing report

Application

Clinical resistance mutation modeling
Target validation with isogenic cell lines
Mechanism of action (MOA) studies
Drug screening for resistance-overcoming agents
Precision oncology research

Protein tagging for localization studies
Reporter gene system development
CAR-T and cell therapy development
Endogenous protein function analysis
Biomarker discovery and validation

Oncology Research Areas

Our gene knockin cell line construction services support a broad spectrum of oncology research, providing precisely engineered cellular models with clinically relevant genetic modifications across diverse cancer types, enabling researchers to model resistance mechanisms, validate drug targets, and elucidate gene function in physiological contexts. Alfa Cytology's platform is adaptable to virtually any tumor cell line of interest, empowering your research across the full spectrum of oncology disciplines, including but not limited to:

Ready to advance your oncology research with our gene knockin cell line construction services? Whether your project requires a clinically relevant point mutation cell line for drug resistance studies, a fluorescently tagged cell line for protein tracking, or a reporter cell line for pathway activity monitoring, Alfa Cytology is fully equipped to assist. Please don't hesitate to contact us to discuss your specific gene knockin cell line needs and discover how our expertise can accelerate your oncology research programs.

Reference

Deleuze V, et al. Protocol for efficient CRISPR-Cas9-mediated fluorescent tag knockin in hard-to-transfect erythroid cell lines. STAR Protoc. 2024;5(2):103016.

For research use only.

Solutions

Online Inquiry

Name *

Email *

Phone *

Services Interested *

Project Description

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.